The active substance Bacillus amyloliquefaciens strain MBI 600, as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Art. 1 Regulation (EU) 2016/1429
Approval of active substance
In forcesince 26 Aug 2016
Approval of active substance
The active substance Bacillus amyloliquefaciens strain MBI 600, as specified in Annex I, is approved subject to the conditions laid down in that Annex.